« Safety of Estrogen-Based Feminizing Gender-Affirming Hormone Therapy:  A Practical Endocrine Approach to Risk Stratification and Monitoring », Can Diabetes Endocrinol Today, vol. 4, nᵒ 1, p. 10–16, mai 2026, doi: 10.58931/cdet.2026.4150.